DoD Anthrax Vaccine Program May Need Second Manufacturer, Senators Say
Executive Summary
The Department of Defense should consider recruiting a second anthrax vaccine manufacturer to compensate for continued delays experienced by Bioport, Sen. Roberts (R-Kan.) indicated during a Senate Armed Services Committee hearing April 13.
You may also be interested in...
BioPort Anthrax Vaccine Production Could Begin Nov. 15 - HHS' Thompson
BioPort could begin production of anthrax vaccine by Nov. 15 if its Lansing, Mich. facility receives FDA approval, HHS Secretary Tommy Thompson told the Senate Governmental Affairs Committee Oct. 17.
BioPort Anthrax Vaccine Production Could Begin Nov. 15 - HHS' Thompson
BioPort could begin production of anthrax vaccine by Nov. 15 if its Lansing, Mich. facility receives FDA approval, HHS Secretary Tommy Thompson told the Senate Governmental Affairs Committee Oct. 17.
BioPort Anthrax Vaccine Production Data To Be Submitted To FDA By Mid-Oct.
Anthrax vaccine manufacturer BioPort plans to submit data to FDA by Oct. 15 for approval of its renovated Lansing, Mich. plant.